Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis
European Journal of Neurology · 2023-11 · 30 (11) · 3471-3477
DOI: 10.1111/ene.15848 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 26.05.2023. Verfasst von Li Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Parkinson Disease. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and purpose Parkinson disease (PD)‐associated alterations in the gut microbiome have been observed in clinical and animal studies. However, it remains unclear whether this association reflects a causal effect in humans.
Methods
We performed two‐sample bidirectional Mendelian randomization using summary statistics from the international consortium MiBioGen ( N = 18,340), the Framingham Heart Study ( N = 2076), and the International Parkinson's Disease Genomics Consortium for PD (33,674 cases and 449,056 controls) and PD age at onset (17,996 cases).
Results
Twelve microbiota features presented suggestive associations with PD risk or age at onset. Genetically increased Bifidobacterium levels correlated with decreased PD risk (odds ratio = 0.77, 95% confidence interval [CI] = 0.60–0.99, p = 0.040). Conversely, high levels of five short‐chain fatty acid (SCFA)‐producing bacteria ( LachnospiraceaeUCG010 , RuminococcaceaeUCG002 , Clostridium sensustricto1 , Eubacterium hallii group, and Bacillales) correlated with increased PD risk, and three SCFA‐producing bacteria ( Roseburia , RuminococcaceaeUCG002 , and Erysipelatoclostridium ) correlated with an earlier age at PD onset. Gut production of serotonin was associated with an earlier age at PD onset (beta = −0.64, 95% CI = −1.15 to −0.13, p = 0.013). In the reverse direction, genetic predisposition to PD was related to altered gut microbiota composition.
Conclusions
These results support a bidirectional relationship between gut microbiome dysbiosis and PD, and highlight the role of elevated endogenous SCFAs and serotonin in PD pathogenesis. Future clinical studies and experimental evidence are needed to explain the observed associations and to suggest new therapeutic approaches, such as dietary probiotic supplementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
- Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
- Bioinformatics Center and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Ji-Feng Guo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, L., Li, J. C., Tang, B. S., & Guo, J. F. (2023). Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis. European Journal of Neurology, 30(11), 3471-3477. https://doi.org/10.1111/ene.15848
Vancouver
Jiang L, Li JC, Tang BS, Guo JF. Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis. European Journal of Neurology. 2023;30(11):3471-3477. doi:10.1111/ene.15848
BibTeX
@article{Jiang2023,
author = {Jiang, Li and Li, Jin-Chen and Tang, Bei-Sha and Guo, Ji-Feng},
title = {Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis},
journal = {European Journal of Neurology},
year = {2023},
volume = {30},
number = {11},
pages = {3471--3477},
doi = {10.1111/ene.15848}
}
EUVIMED